Stock Research: PolyPeptide

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

PolyPeptide

SWX:PPGN CH1110760852
8
  • Value
    49
  • Growth
    55
  • Safety
    Safety
    14
  • Combined
    25
  • Sentiment
    6
  • 360° View
    360° View
    8
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 8 (better than 8% compared with alternatives), overall professional sentiment and financial characteristics for the stock PolyPeptide are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for PolyPeptide. The consolidated Growth Rank has a good rank of 55, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 55% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 14 means that the share price of PolyPeptide is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 86% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 49, which means that the company has a riskier financing structure than 51% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 6, indicating professional investors are more pessimistic about the stock than for 94% of alternative investment opportunities. ...read more

more
Index
SPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 32 51 21
Growth
55 96 1 59
Safety
Safety
49 49 78 78
Sentiment
6 16 1 30
360° View
360° View
8 49 8 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
28 17 1 37
Opinions Change
13 50 50 18
Pro Holdings
n/a 17 1 72
Market Pulse
45 79 14 46
Sentiment
6 16 1 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 32 51 21
Growth
55 96 1 59
Safety Safety
49 49 78 78
Combined
25 76 32 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 3 83 25
Price vs. Earnings (P/E)
41 56 62 20
Price vs. Book (P/B)
51 58 83 14
Dividend Yield
1 26 1 34
Value
14 32 51 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
85 92 75 72
Profit Growth
67 96 1 68
Capital Growth
17 49 7 29
Stock Returns
37 86 11 65
Growth
55 96 1 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
64 66 80 62
Refinancing
61 62 79 49
Liquidity
10 7 37 65
Safety Safety
49 49 78 78

Similar Stocks

Discover high‑ranked alternatives to PolyPeptide and broaden your portfolio horizons.

ALSO

SWX:ALSN
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

SoftwareONE Holding

SWX:SWON
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.